Skip to content
healthcare.dev
Get a free key

OLOPATADINE HYDROCHLORIDE

NDC 72657-168, Olopatadine Hydrochloride ophthalmic, solution, from GLENMARK THERAPEUTICS INC., USA.

Product NDC
72657-168
Status
Listed
Labeler
GLENMARK THERAPEUTICS INC., USA
Dosage form
SOLUTION
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA200810
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72657-168 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE1 mg/mL

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
72657-168-50726570168501 BOTTLE, PLASTIC in 1 CARTON (72657-168-50) / 5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 72657-168 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72657-168 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72657-168. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.